| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5503842 | Parkinsonism & Related Disorders | 2017 | 20 Pages |
Abstract
Results suggest that in the context of early stage Parkinson's disease, the Montreal Cognitive Assessment is a unidimensional measure of global cognitive function. Implications for the use of the Montreal Cognitive Assessment in early stage Parkinson's disease and potential improvements to the assessment are discussed.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Sandra L. Kletzel, Juan Manuel Hernandez, Elizabeth F. Miskiel, Trudy Mallinson, Theresa Louise-Bender Pape,